VIR is Vir Biotechnology, Inc. (Healthcare) — a non-dividend-paying stock. Trading at $11.38. Market cap: $1.94B. Capital Quality Rank: 44/100 — Stagnant mediocrity.
Stock snapshot
| Price | $11.38 |
| Market cap | $1.94B |
| Sector | Healthcare |
| Exchange | NMS |
| Pays dividend | No |
Capital Quality & fundamentals
DiviDrip's Capital Analytics engine ranks every non-dividend stock 1-100 on a 4-factor composite (Shareholder Yield 30%, Cash-Flow ROI 25%, Operating Momentum 25%, Tail-Risk 20%) — sector-neutralized so a biotech isn't penalized for negative earnings the way a utility would be.
| Capital Quality Rank (1-100) | 44 / 100 · Stagnant mediocrity |
| ROIC (TTM) | -71.0% |
| Revenue CAGR (3y) | -65.1% |
| Shareholder buyback yield | -1.64% |
| Altman Z-score zone | Distress |
About VIR
Vir Biotechnology Inc is a clinical-stage biopharmaceutical company focused on powering the immune system by discovering and developing medicines for serious infectious diseases and cancer. The company uses its capabilities in antibody discovery and engineering, coupled with its proprietary AI engine dAIsY system, and the PRO-XTEN masking platform, to quickly and effectively discover and optimize potential new medicines. Its clinical development pipeline consists of investigational therapies like Tobevibart + elebsiran targeting the hepatitis delta virus (HDV), preclinical antibody candidates targeting HIV, and VIR-5500, VIR-5818, VIR-5525, and 7 PRO-XTEN programs targeting multiple solid tumors. Currently, the company generates revenue mainly by issuing license rights and through grants.
Related non-dividend companies
Other non-dividend stocks investors research alongside VIR. Peer set from Massive news + returns similarity, filtered to names we currently track.
Frequently asked
What is VIR's current stock price?
VIR (Vir Biotechnology, Inc.) is currently trading at $11.38.
Does VIR pay a dividend?
VIR (Vir Biotechnology, Inc.) does not currently pay a regular dividend.
What is VIR's Capital Quality Rank?
VIR has a Capital Quality Rank of 44/100 — Stagnant mediocrity. This score blends ROIC, revenue growth, buybacks, and balance-sheet health.
Track VIR in DiviDrip
Add VIR to your watchlist on DiviDrip to monitor price, fundamentals, and Capital Quality Rank week-over-week. Built for long-term investors tracking both dividend and non-dividend names.
- Open DiviDrip — search VIR and add it to your watchlist.
- Stock Screener — filter by sector, market cap, and Capital Quality Rank.
- How to use the Screener — sector / quality / market-cap filters explained.
Data refreshed 2026-09-05. Not investment advice. Prices change continuously; always verify the latest numbers in the live app before buying.